At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy (Q36935749)

From Wikidata
Jump to navigation Jump to search
scientific article published on 26 April 2013
edit
Language Label Description Also known as
English
At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy
scientific article published on 26 April 2013

    Statements

    At the bench: preclinical rationale for CTLA-4 and PD-1 blockade as cancer immunotherapy (English)

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit